Search
Abbott Laboratories
ABTAdd to Watchlist
103.700USD
+1.190+1.16%
Close 10-23 16:00（ET）
179.44BMarket Cap
28.77P/E TTM
After-hours 19:00 (ET)103.700USD0.000
After-hours 19:00 (ET)Abbott Laboratories (ABT) Revenue Performance
Updated: Jun 30, 2026Last year, Abbott Laboratories generated 8.00B USD for its biggest-performing segment, Diabetes Care. The United States made the largest contribution, accounting for 17.13B USD last year. For the latest quarter, Abbott Laboratories reported the revenue of 2.19B USD for the period ending 2026-06-30, which came from the top-performing segment, Diabetes Care. All other Countries contributed the highest revenue, at 7.38B USD.
By Business
Revenue
Proportion
Annual
Annual
Quarterly
Diabetes Care
Core Laboratory
Adult Nutritionals
Key Emerging Markets
Pediatric Nutritionals
Vascular
Electrophysiology
Rhythm Management
Structural Heart
Rapid Diagnostics
Heart Failure
Other
Neuromodulation
Point of Care
Molecular
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Diabetes Care
8.00B(18.04%)
6.80B(16.22%)
5.76B(14.36%)
4.76B(10.90%)
4.33B(10.05%)
3.27B(9.44%)
Core Laboratory
5.36B(12.09%)
5.24B(12.48%)
5.16B(12.86%)
4.89B(11.20%)
5.13B(11.90%)
4.47B(12.93%)
Adult Nutritionals
4.48B(10.10%)
4.39B(10.46%)
4.22B(10.52%)
3.98B(9.11%)
4.00B(9.28%)
3.52B(10.17%)
Key Emerging Markets
4.17B(9.40%)
3.86B(9.20%)
3.81B(9.49%)
3.73B(8.54%)
3.54B(8.22%)
3.21B(9.27%)
Pediatric Nutritionals
3.97B(8.96%)
4.02B(9.59%)
3.93B(9.81%)
3.48B(7.97%)
4.30B(9.98%)
4.13B(11.92%)
Vascular
3.00B(6.76%)
2.84B(6.76%)
2.68B(6.68%)
2.48B(5.69%)
2.65B(6.16%)
2.34B(6.76%)
Electrophysiology
2.76B(6.24%)
2.47B(5.88%)
2.19B(5.47%)
1.93B(4.41%)
1.91B(4.43%)
1.58B(4.56%)
Rhythm Management
2.65B(5.98%)
2.39B(5.70%)
2.25B(5.62%)
2.12B(4.85%)
2.20B(5.10%)
1.91B(5.53%)
Structural Heart
2.52B(5.69%)
2.25B(5.35%)
1.94B(4.85%)
1.71B(3.92%)
1.61B(3.74%)
1.25B(3.60%)
Rapid Diagnostics
2.45B(5.54%)
3.00B(7.14%)
3.69B(9.20%)
10.18B(23.31%)
8.55B(19.86%)
4.38B(12.64%)
Heart Failure
1.45B(3.27%)
1.28B(3.05%)
1.16B(2.89%)
920.00M(2.11%)
889.00M(2.06%)
740.00M(2.14%)
Other
1.39B(3.13%)
1.35B(3.22%)
1.27B(3.17%)
1.20B(2.74%)
1.23B(2.86%)
1.16B(3.35%)
Neuromodulation
1.01B(2.28%)
962.00M(2.29%)
890.00M(2.22%)
770.00M(1.76%)
781.00M(1.81%)
702.00M(2.03%)
Point of Care
606.00M(1.37%)
588.00M(1.40%)
565.00M(1.41%)
525.00M(1.20%)
536.00M(1.24%)
516.00M(1.49%)
Molecular
517.00M(1.17%)
521.00M(1.24%)
574.00M(1.43%)
995.00M(2.28%)
1.43B(3.31%)
1.44B(4.16%)
By Region
Revenue
Proportion
Annual
Annual
Quarterly
United States
All other Countries
Germany
China
India
Switzerland
Japan
United Kingdom
India
The Netherlands
Canada
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
United States
17.13B(38.63%)
16.32B(38.91%)
15.45B(38.53%)
18.14B(41.56%)
16.64B(38.63%)
13.02B(37.63%)
11.40B(35.73%)
All other Countries
15.98B(36.05%)
14.85B(35.39%)
14.08B(35.11%)
14.84B(34.00%)
15.52B(36.02%)
12.58B(36.35%)
11.53B(36.15%)
Germany
2.76B(6.22%)
2.54B(6.05%)
2.35B(5.85%)
2.34B(5.36%)
2.57B(5.97%)
2.11B(6.09%)
1.75B(5.49%)
China
1.91B(4.30%)
2.11B(5.04%)
2.25B(5.62%)
2.13B(4.89%)
2.39B(5.55%)
1.97B(5.68%)
2.35B(7.35%)
India
1.87B(4.22%)
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
Switzerland
1.87B(4.22%)
1.75B(4.16%)
1.64B(4.08%)
1.34B(3.06%)
1.31B(3.05%)
1.14B(3.29%)
1.07B(3.35%)
Japan
1.48B(3.33%)
1.44B(3.44%)
1.51B(3.77%)
1.93B(4.43%)
1.70B(3.93%)
1.39B(4.00%)
1.44B(4.50%)
United Kingdom
1.34B(3.02%)
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
India
--(--)
1.82B(4.33%)
1.75B(4.36%)
1.65B(3.78%)
1.56B(3.62%)
1.32B(3.82%)
1.40B(4.38%)
The Netherlands
--(--)
1.12B(2.68%)
1.07B(2.68%)
--(--)
--(--)
1.08B(3.13%)
975.00M(3.06%)
Canada
--(--)
--(--)
--(--)
1.28B(2.93%)
1.39B(3.22%)
--(--)
--(--)